XML 64 R29.htm IDEA: XBRL DOCUMENT v3.24.4
Commitments (Details) - USD ($)
 9 Months Ended 12 Months Ended
Jan. 21, 2024
Jan. 11, 2024
Dec. 11, 2023
Apr. 04, 2023
Jan. 07, 2022
Sep. 30, 2024
Dec. 31, 2023
Commitments [Line Items]              
Underwriting discount per share (in Dollars per share)           $ 0.2 $ 0.2
Cash underwriting discount           $ 6,000,000 $ 6,000,000
Deferred fee per unit (in Dollars per share)           $ 0.35 $ 0.35
Underwriters deferred fee           $ 10,500,000 $ 10,500,000
Percentage of gross proceeds   4.00%          
Net tangible assets           5,000,001  
Closing cash           $ 8,700,000  
Net tangible assets       $ 5,000,001      
Commitments least cost       $ 8,700,000      
Underwriter [Member]              
Commitments [Line Items]              
underwriter waived fee $ 4,290,000            
Common stock shares (in Shares) 600,000            
Advisor [Member]              
Commitments [Line Items]              
Common stock shares (in Shares)   200,000          
Non-Redemption Agreements [Member]              
Commitments [Line Items]              
Number of shares not available for redemption. (in Shares)       3,300,900      
Aggregate of investor shares (in Shares)       825,225      
Sponsor Letter Agreement [Member]              
Commitments [Line Items]              
Sponsor letter agreement, description     Sponsor agrees to (i) retain 2.95 million shares of the Company’s Series A common stock held by it, (ii) divide 2,458,333 shares of the Company’s Series A Common Stock held by it among the Sponsor, who will be entitled to 491,667 of the shares, Abpro, who will be entitled to 983,333 of the shares, and Abpro Bio Co., Ltd, who will be entitled to 983,333 of the shares, for such party to use to obtain non-redemption commitments from the Company’s stockholders or other capital for ACAB or the Surviving Company (with any shares unused for such purpose to be retained by such party) and (ii) forfeit the remainder of any the Company’s Series A common stock and the Company’s Series B common stock held by it.        
Sponsor Letter Agreement [Member] | Sponser [Member]              
Commitments [Line Items]              
Sponsor letter agreement, description     Sponsor agrees to (i) retain 2.95 million shares of the Company’s Series A Common Stock held by it, (ii) divide 2,458,333 shares of the Company’s Series A Common Stock held by it among the Sponsor, who will be entitled to 491,667 of the shares, Abpro, who will be entitled to 983,333 of the shares, and Abpro Bio Co., Ltd, who will be entitled to 983,333 of the shares, for such party to use to obtain non-redemption commitments from the Company’s stockholders or other capital for ACAB or the Surviving Company (with any shares unused for such purpose to be retained by such party) and (ii) forfeit the remainder of any the Company’s Series A Common Stock and the Company’s Series B Common Stock held by it.        
Non-Redemption Agreement [Member]              
Commitments [Line Items]              
Number of shares not available for redemption. (in Shares)       3,300,900      
Aggregate of investor shares (in Shares)       825,225      
Initial Public Offering [Member]              
Commitments [Line Items]              
Percentage of advisory services fee         0.08%    
Advisory services fee         $ 240,000